158 related articles for article (PubMed ID: 36347832)
21. Blast cells surviving acute myeloid leukemia induction therapy are in cycle with a signature of FOXM1 activity.
Williams MS; Basma NJ; Amaral FMR; Wiseman DH; Somervaille TCP
BMC Cancer; 2021 Oct; 21(1):1153. PubMed ID: 34711181
[TBL] [Abstract][Full Text] [Related]
22. Cephalotaxine Inhibits the Survival of Leukemia Cells by Activating Mitochondrial Apoptosis Pathway and Inhibiting Autophagy Flow.
Liu T; Guo Q; Zheng S; Liu Y; Yang H; Zhao M; Yao L; Zeng K; Tu P
Molecules; 2021 May; 26(10):. PubMed ID: 34070111
[TBL] [Abstract][Full Text] [Related]
23. The role of autophagy in targeted therapy for acute myeloid leukemia.
Du W; Xu A; Huang Y; Cao J; Zhu H; Yang B; Shao X; He Q; Ying M
Autophagy; 2021 Oct; 17(10):2665-2679. PubMed ID: 32917124
[TBL] [Abstract][Full Text] [Related]
24. Autophagy Proteins ATG5 and ATG7 Are Essential for the Maintenance of Human CD34(+) Hematopoietic Stem-Progenitor Cells.
Gomez-Puerto MC; Folkerts H; Wierenga AT; Schepers K; Schuringa JJ; Coffer PJ; Vellenga E
Stem Cells; 2016 Jun; 34(6):1651-63. PubMed ID: 26930546
[TBL] [Abstract][Full Text] [Related]
25. Knockdown of BNIP3L or SQSTM1 alters cellular response to mitochondria target drugs.
Rodrigo R; Mendis N; Ibrahim M; Ma C; Kreinin E; Roma A; Berg S; Blay J; Spagnuolo PA
Autophagy; 2019 May; 15(5):900-907. PubMed ID: 30563411
[TBL] [Abstract][Full Text] [Related]
26. Casein kinase 1α inhibits p53 downstream of MDM2‑mediated autophagy and apoptosis in acute myeloid leukemia.
Xu W; Huang Z; Gan Y; Chen R; Huang Y; Xue B; Jiang S; Yu Z; Yu K; Zhang S
Oncol Rep; 2020 Nov; 44(5):1895-1904. PubMed ID: 32901886
[TBL] [Abstract][Full Text] [Related]
27. The combination of a histone deacetylase inhibitor with the BH3-mimetic GX15-070 has synergistic antileukemia activity by activating both apoptosis and autophagy.
Wei Y; Kadia T; Tong W; Zhang M; Jia Y; Yang H; Hu Y; Viallet J; O'Brien S; Garcia-Manero G
Autophagy; 2010 Oct; 6(7):976-8. PubMed ID: 20729640
[TBL] [Abstract][Full Text] [Related]
28. Disruption of Wnt/β-Catenin Exerts Antileukemia Activity and Synergizes with FLT3 Inhibition in
Jiang X; Mak PY; Mu H; Tao W; Mak DH; Kornblau S; Zhang Q; Ruvolo P; Burks JK; Zhang W; McQueen T; Pan R; Zhou H; Konopleva M; Cortes J; Liu Q; Andreeff M; Carter BZ
Clin Cancer Res; 2018 May; 24(10):2417-2429. PubMed ID: 29463558
[No Abstract] [Full Text] [Related]
29. A combination of temsirolimus, an allosteric mTOR inhibitor, with clofarabine as a new therapeutic option for patients with acute myeloid leukemia.
Chiarini F; Lonetti A; Teti G; Orsini E; Bressanin D; Cappellini A; Ricci F; Tazzari PL; Ognibene A; Falconi M; Pagliaro P; Iacobucci I; Martinelli G; Amadori S; McCubrey JA; Martelli AM
Oncotarget; 2012 Dec; 3(12):1615-28. PubMed ID: 23271044
[TBL] [Abstract][Full Text] [Related]
30. Idarubicin induces mTOR-dependent cytotoxic autophagy in leukemic cells.
Ristic B; Bosnjak M; Arsikin K; Mircic A; Suzin-Zivkovic V; Bogdanovic A; Perovic V; Martinovic T; Kravic-Stevovic T; Bumbasirevic V; Trajkovic V; Harhaji-Trajkovic L
Exp Cell Res; 2014 Aug; 326(1):90-102. PubMed ID: 24907655
[TBL] [Abstract][Full Text] [Related]
31. Enhancement of Quercetin-Induced Apoptosis by Cotreatment with Autophagy Inhibitor Is Associated with Augmentation of BAK-Dependent Mitochondrial Pathway in Jurkat T Cells.
Ha EJ; Kim KY; Kim CE; Jun DY; Kim YH
Oxid Med Cell Longev; 2019; 2019():7989276. PubMed ID: 31827702
[TBL] [Abstract][Full Text] [Related]
32. Cotargeting BCL-2 and PI3K Induces BAX-Dependent Mitochondrial Apoptosis in AML Cells.
Rahmani M; Nkwocha J; Hawkins E; Pei X; Parker RE; Kmieciak M; Leverson JD; Sampath D; Ferreira-Gonzalez A; Grant S
Cancer Res; 2018 Jun; 78(11):3075-3086. PubMed ID: 29559471
[TBL] [Abstract][Full Text] [Related]
33. Restoration of Autophagic Flux Rescues Oxidative Damage and Mitochondrial Dysfunction to Protect against Intervertebral Disc Degeneration.
Kang L; Xiang Q; Zhan S; Song Y; Wang K; Zhao K; Li S; Shao Z; Yang C; Zhang Y
Oxid Med Cell Longev; 2019; 2019():7810320. PubMed ID: 31976028
[TBL] [Abstract][Full Text] [Related]
34. A New Strategy to Target Acute Myeloid Leukemia Stem and Progenitor Cells Using Chidamide, a Histone Deacetylase Inhibitor.
Li Y; Chen K; Zhou Y; Xiao Y; Deng M; Jiang Z; Ye W; Wang X; Wei X; Li J; Liang J; Zheng Z; Yao Y; Wang W; Li P; Xu B
Curr Cancer Drug Targets; 2015; 15(6):493-503. PubMed ID: 26282548
[TBL] [Abstract][Full Text] [Related]
35. IL-1β inhibits self-renewal capacity of dormant CD34⁺/CD38⁻ acute myelogenous leukemia cells in vitro and in vivo.
Yang J; Ikezoe T; Nishioka C; Nobumoto A; Yokoyama A
Int J Cancer; 2013 Oct; 133(8):1967-81. PubMed ID: 23564444
[TBL] [Abstract][Full Text] [Related]
36. Nicotinamide phosphoribosyltransferase inhibitors selectively induce apoptosis of AML stem cells by disrupting lipid homeostasis.
Subedi A; Liu Q; Ayyathan DM; Sharon D; Cathelin S; Hosseini M; Xu C; Voisin V; Bader GD; D'Alessandro A; Lechman ER; Dick JE; Minden MD; Wang JCY; Chan SM
Cell Stem Cell; 2021 Oct; 28(10):1851-1867.e8. PubMed ID: 34293334
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA-143 sensitizes acute myeloid leukemia cells to cytarabine via targeting ATG7- and ATG2B-dependent autophagy.
Zhang H; Kang J; Liu L; Chen L; Ren S; Tao Y
Aging (Albany NY); 2020 Oct; 12(20):20111-20126. PubMed ID: 33077697
[TBL] [Abstract][Full Text] [Related]
38. Protein Kinase C Epsilon Is a Key Regulator of Mitochondrial Redox Homeostasis in Acute Myeloid Leukemia.
Di Marcantonio D; Martinez E; Sidoli S; Vadaketh J; Nieborowska-Skorska M; Gupta A; Meadows JM; Ferraro F; Masselli E; Challen GA; Milsom MD; Scholl C; Fröhling S; Balachandran S; Skorski T; Garcia BA; Mirandola P; Gobbi G; Garzon R; Vitale M; Sykes SM
Clin Cancer Res; 2018 Feb; 24(3):608-618. PubMed ID: 29127121
[No Abstract] [Full Text] [Related]
39. Inhibition of mTOR-dependent autophagy sensitizes leukemic cells to cytarabine-induced apoptotic death.
Bosnjak M; Ristic B; Arsikin K; Mircic A; Suzin-Zivkovic V; Perovic V; Bogdanovic A; Paunovic V; Markovic I; Bumbasirevic V; Trajkovic V; Harhaji-Trajkovic L
PLoS One; 2014; 9(4):e94374. PubMed ID: 24714637
[TBL] [Abstract][Full Text] [Related]
40. Targeting the metabolic vulnerability of acute myeloid leukemia blasts with a combination of venetoclax and 8-chloro-adenosine.
Buettner R; Nguyen LXT; Morales C; Chen MH; Wu X; Chen LS; Hoang DH; Hernandez Vargas S; Pullarkat V; Gandhi V; Marcucci G; Rosen ST
J Hematol Oncol; 2021 Apr; 14(1):70. PubMed ID: 33902674
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]